ArticleScientific reports2025
Human umbilical vein endothelial cell miRNA secretome highlights endothelial origin of serum miRNAs.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Nature versus nurture: genetic background and media composition shape endothelial cell transcriptomes in vitro.Scientific reports · 2026Article
- Endothelial progenitor cells and circulating microRNAs as possible biomarkers for coronary artery disease.Frontiers in aging · 2026Article
- MicroRNAs orchestrating host and vector-borne protozoan interactions: bridging immune modulation and cross-species communication.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MicroRNAs are key contributors to blood-based biomarker research, however their potential is hindered by the "noise" of their abundance even in healthy blood. Using HUVEC cultures and their conditioned media as a model for endothelium and blood, we were able to detect 574 different microRNAs. 166 of these were exclusively secreted, 155 only intracellular and 253 were found in both states suggesting a highly ordered role in endocrine and paracrine communication. The identified microRNA signatures exhibited higher degrees of variability based on culture conditions rather than genetic background of donors. We found that the endothelial secreted microRNA signature correlates greatly with those found in blood serum (ρ = 0.749 ± 0.044), more so, than leukocyte secretory microRNAs (ρ = 0.531 ± 0.044). These results demonstrate that the endothelium actively secretes microRNAs dominating the microRNA composition of the blood making the endothelial secretory microRNA signatures ideal representation of background "noise" of healthy serum samples. These microRNA signatures are readily adapted to environmental cues; making the standardisation of culture conditions a key concern. Our results also demonstrate that the microarray technology has great use in precision microRNA biomarker discovery using simple models, which should be utilised for further mapping of cell-type specific healthy signatures to further refine blood-based diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.